NCT07212491View on ClinicalTrials.gov

Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma- Renewal Grant Aim 2 (The SOS6C Trial)

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Barrett EsophagusEsophageal Adenocarcinoma
Interventions
OTHER

Non-Interventional Study

Non-interventional study

Trial Locations (3)

55905

Mayo Clinic in Rochester, Rochester

85259

Mayo Clinic in Arizona, Scottsdale

32224-9980

Mayo Clinic in Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER

NCT07212491 - Minimally Invasive Molecular Approaches for the Detection of Barrett's Esophagus- High Grade Dysplasia and Esophageal Adenocarcinoma- Renewal Grant Aim 2 (The SOS6C Trial) | Biotech Hunter | Biotech Hunter